BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

526546

CHOKSILA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CHOKSI LABORATORIES LTD. Share Price Update

As of the latest trading session, CHOKSI LABORATORIES LTD. share price is currently at ₹ 203.8, which is up by ₹ 3.55 from its previous closing. Today, the stock has fluctuated between ₹ 192.00 and ₹ 204.90. Over the past year, CHOKSI LABORATORIES LTD. has achieved a return of 167.00 %. In the last month alone, the return has been 8.50 %. Read More...

Investment Returns

Over 1 Month 8.50% Over 3 Months 68.41% Over 6 Months 65.08% Over 1 Year 167.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CHOKSI LABORATORIES LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    142.00

  • P/E Ratio (TTM)

    93.57

  • Beta

    0.78

  • Book Value / share

    33.88

  • Return on equity

    6.63%

  • EPS (TTM)

    2.14

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.39

info icon alternate text

CHOKSI LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 11.24
Operating Expense 10.62
Net Profit 0.39
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.55
EBITDA 2.91
Effective Tax Rate (%) 38.09
Particulars MAR 2025 (Values in Cr)
Revenue 11.40
Operating Expense 10.18
Net Profit 0.92
Net Profit Margin (%) 8.07
Earnings Per Share (EPS) 1.32
EBITDA 3.54
Effective Tax Rate (%) 26.98
Particulars DEC 2024 (Values in Cr)
Revenue 10.38
Operating Expense 10.20
Net Profit 0.11
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.15
EBITDA 2.55
Effective Tax Rate (%) 44.44
Particulars SEP 2024 (Values in Cr)
Revenue 9.26
Operating Expense 9.18
Net Profit 0.08
Net Profit Margin (%) 0.86
Earnings Per Share (EPS) 0.11
EBITDA 2.37
Effective Tax Rate (%) 20.00
Particulars JUN 2024 (Values in Cr)
Revenue 10.74
Operating Expense 10.13
Net Profit 0.42
Net Profit Margin (%) 3.91
Earnings Per Share (EPS) 0.60
EBITDA 2.84
Effective Tax Rate (%) 30.64
Particulars MAR 2025 (Values in Cr)
Revenue 41.78
Operating Expense 39.69
Net Profit 1.52
Net Profit Margin (%) 3.63
Earnings Per Share (EPS) 2.19
EBITDA 11.30
Effective Tax Rate (%) 29.30
Particulars MAR 2024 (Values in Cr)
Revenue 36.70
Operating Expense 35.19
Net Profit 1.11
Net Profit Margin (%) 3.02
Earnings Per Share (EPS) 1.59
EBITDA 10.37
Effective Tax Rate (%) 33.13
Particulars MAR 2023 (Values in Cr)
Revenue 34.44
Operating Expense 33.19
Net Profit 3.21
Net Profit Margin (%) 9.32
Earnings Per Share (EPS) 4.61
EBITDA 12.71
Effective Tax Rate (%) 13.70
Particulars MAR 2022 (Values in Cr)
Revenue 30.04
Operating Expense 29.80
Net Profit 0.21
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.30
EBITDA 9.01
Effective Tax Rate (%) 43.24
Particulars MAR 2021 (Values in Cr)
Revenue 25.69
Operating Expense 28.98
Net Profit -2.61
Net Profit Margin (%) -10.15
Earnings Per Share (EPS) -3.74
EBITDA 4.56
Effective Tax Rate (%) 7.11
Particulars MAR 2025 (Values in Cr)
Book Value / Share 33.89
ROE % 6.63
ROCE % 8.89
Total Debt to Total Equity 1.31
EBITDA Margin 27.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.89
ROE % 5.12
ROCE % 8.58
Total Debt to Total Equity 1.46
EBITDA Margin 28.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.31
ROE % 8.41
ROCE % 8.92
Total Debt to Total Equity 1.79
EBITDA Margin 30.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 25.70
ROE % 1.18
ROCE % 6.29
Total Debt to Total Equity 2.14
EBITDA Margin 30.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.48
ROE % -13.74
ROCE % 0.02
Total Debt to Total Equity 1.86
EBITDA Margin 17.94
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 65.33
Total Liabilities 65.33
Total Equity 23.60
Share Outstanding 6965000
Price to Book Ratio 3.55
Return on Assets (%) 2.33
Return on Capital (%) 2.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.65
Total Assets 61.95
Total Liabilities 61.95
Total Equity 22.21
Share Outstanding 6965000
Price to Book Ratio 1.33
Return on Assets (%) 1.79
Return on Capital (%) 2.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 60.36
Total Liabilities 60.36
Total Equity 21.10
Share Outstanding 6965263
Price to Book Ratio 1.10
Return on Assets (%) 5.31
Return on Capital (%) 6.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 64.41
Total Liabilities 64.41
Total Equity 17.90
Share Outstanding 6965263
Price to Book Ratio 0.99
Return on Assets (%) 0.32
Return on Capital (%) 0.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 66.38
Total Liabilities 66.38
Total Equity 17.74
Share Outstanding 6965263
Price to Book Ratio 0.31
Return on Assets (%) -3.92
Return on Capital (%) -4.83
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 13.77
Cash from Investing -7.60
Cash from Financing -4.21
Net change in Cash -0.04
Free Cash Flow 21.21
Particulars MAR 2024 (Values in Cr)
Net Income 1.66
Cash from Operations 12.04
Cash from Investing -6.64
Cash from Financing -4.58
Net change in Cash 0.31
Free Cash Flow 16.39
Particulars MAR 2023 (Values in Cr)
Net Income 3.72
Cash from Operations 7.50
Cash from Investing -0.70
Cash from Financing -7.61
Net change in Cash -0.06
Free Cash Flow 11.44
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations 6.70
Cash from Investing -2.70
Cash from Financing -5.06
Net change in Cash 0.10
Free Cash Flow 7.68
Particulars MAR 2021 (Values in Cr)
Net Income -2.80
Cash from Operations 2.78
Cash from Investing -7.64
Cash from Financing 1.62
Net change in Cash -0.11
Free Cash Flow 10.33
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 70.15 13.45 110382.76 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 67.36 27.38 4.18 126.24 51.01 / 98.70
SHREE PACETRONIX LTD. 167.30 57.69 4.36 60.22 61.11 / 187.00
TRANSGENE BIOTEK LTD. 3.99 0.00 3.01 30.23 3.22 / 8.88
VIMTA LABS LIMITED 656.00 48.02 8.51 2919.57 254.43 / 728.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 81.68 12.63 110382.76 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.98 0.00 -15.01 28.37 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6299.05 31.26 6.34 6891.16 4777.15 / 6525.00

CHOKSI LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
203.80 1.77 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 207.10
  • 26 Days 204.20
  • 10 Days 210.20
  • 50 Days 191.50
  • 12 Days 210.10
  • 100 Days 169.80
  • 20 Days 207.20
  • 200 Days 142.00
201.78 PIVOT

First Support

198.57

First Resistance

203.47

Second Support

196.88

Second Resistance

206.68

Third Support

193.67

Third Resistance

208.37

RSI

47.03

ADX

23.51

MACD

5.85

Williams % R

-87.41

Commodity Channel Index (CCI)

-41.93

Date

2025-09-01

Week

5777.00

Same Day

2293.00

Month

11766.00

1 Year

0.79

3 Year

0.97

Over 1 Month

8.50%

down

Over 1 Year

167.00%

down

Over 3 Months

68.41%

down

Over 3 Years

89.12%

down

Over 6 Months

65.08%

down

Over 5 Years

83.13%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

CHOKSI LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

CHOKSI LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

CHOKSI LABORATORIES LTD. Share Price

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services. CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries. The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services.

The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day. It provides calibration of production & quality control equipment with traceability to national / international standards. This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects. This requires a detailed knowledge of the industry sector as well as the client's business processes. CLL has expertise in setting up in-house labs for a large number of clients, which provide consultancy, training & independent auditing for Quality Management Systems.

The Company started its unit at Vapi (Gujarat) and also got registered with FDA department during 2002. It started the laboratory at Chandigarh in 2005; thereafter the Goa Lab in 2011 and calibration of Bangalore operation from May 2011.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Choksi Laboratories Ltd?

Answer Field

Choksi Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 203.80 as on Sep 02 2025 03:25 PM.

What is the Market Cap of Choksi Laboratories Ltd Share?

Answer Field

The market cap of Choksi Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 142.00 as on Sep 02 2025 03:25 PM.

What is the 52 Week High and Low of Choksi Laboratories Ltd?

Answer Field

The 52 Week High and Low of Choksi Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 236.70 and ₹ 56.16.

What is 1 year return for Choksi Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 167.00%.

What is the P/E Ratio of Choksi Laboratories Ltd Share?

Answer Field

As on Sep 02 2025 03:25 PM the price-to-earnings (PE) ratio for Choksi Laboratories Ltd share is 93.57.

What is the PB ratio of Choksi Laboratories Ltd Share?

Answer Field

As on Sep 02 2025 03:25 PM, the price-to-book (PB) ratio for Choksi Laboratories Ltd share is 33.88.

How to Buy Choksi Laboratories Ltd Share?

Answer Field

You can trade in Choksi Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Choksi Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Choksi Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Choksi Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91